Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Triapine |
| Trade Name | |
| Synonyms | 3-AP|3-Apct|OCX-191|OCX 191|OCX191 |
| Drug Descriptions |
Triapine is an inhibitor of ribonucleotide reductase that blocks DNA synthesis, which potentially reduces cell viability and inhibits tumor growth (PMID: 10692563). |
| DrugClasses | |
| CAS Registry Number | 236392-56-6 |
| NCIT ID | C2242 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cediranib + Olaparib + Triapine | Cediranib Olaparib Triapine | 0 | 0 |
| Cediranib + Triapine | Cediranib Triapine | 0 | 0 |
| Cisplatin + Triapine | Cisplatin Triapine | 0 | 2 |
| Lutetium Lu 177 dotatate + Triapine | Lutetium Lu 177 dotatate Triapine | 0 | 2 |
| Olaparib + Triapine | Olaparib Triapine | 0 | 0 |
| Temozolomide + Triapine | Temozolomide Triapine | 0 | 1 |
| Triapine | Triapine | 0 | 1 |